Purchase Order 75F40124P00140
Award Date 4/26/24
Potential Completion Date 9/30/25
Potential Value $40K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed price purchase order awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc. for $24,357.60 to provide PacBio reagents. The contract has a completion date of September 30, 2024 and does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are used by federal agencies like the FDA, CDC, USDA, and NIH to support genomic research across...
- This is a $46,512 firm-fixed price purchase order awarded by the U.S. Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc., a small business manufacturer, for the delivery of reagents and consumables compatible with the FDA's PacBio Revio DNA/RNA sequencing instrument. The award is the result of a small business set-aside solicitation for these specialized sequencing supplies to support the FDA National Center for Toxicological Research's (NCTR) error-corrected...
- The U.S. Food and Drug Administration awarded a Firm Fixed Price Purchase Order contract to Pacific Biosciences of California, Inc., a small business manufacturer, for the delivery of PacBio Revio sequencing reagent kits or equal products. The $48,715.20 contract has a completion date of September 30, 2024 and will support research at the FDA's National Center for Toxicological Research. This award is associated with a larger $1 million single-award Indefinite Delivery Indefinite Quantity (IDIQ)...
- This is a purchase order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc. The contract is for $138,848.00 and is a firm fixed price agreement. The contract provides Pacific Biosciences, a manufacturer of scientific equipment, reagents, and services, the opportunity to deliver their proprietary Sequel and Sequel II DNA/RNA sequencing systems, along with associated consumables and software, to...
- This is a $10,775.28 firm-fixed price delivery order contract awarded by the Plains Area agency of the U.S. federal government to Pacific Biosciences of California, Inc. for the provision of PacBio Revio reagents and consumables to support whole genome sequencing projects. The contract has an ultimate completion date of September 6, 2024. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are widely utilized by various...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc. for a "SERVICE AGREEMENT FOR RSII: BASE & FOUR (4) OPTION YEARS". The contract has a ceiling value of $420,000.00 and a period of performance through July 22, 2020. Pacific Biosciences is a small business manufacturer that specializes in providing high-throughput, long-read DNA sequencing systems and associated consumables to federal agencies....
- This federal contract award is for the procurement of PacBio Sequel II and IIe system reagents and consumables by the Food and Drug Administration (FDA). The $15,713.10 firm-fixed price contract was awarded on July 23, 2024 to Pacific Biosciences of California, Inc., a leading manufacturer of high-throughput, long-read DNA sequencing platforms and associated products. The contract does not have a set-aside designation. Pacific Biosciences holds two relevant Indefinite Delivery Indefinite...
- This contract award is for the purchase of reagents and supplies from Pacific Biosciences of California, Inc. by the U.S. Department of Health and Human Services' Food and Drug Administration. The items include PacBio's proprietary single molecule real-time (SMRT) sequencing consumables such as template prep kits, binding kits, and SMRT cells to support the agency's genomic research initiatives. The $46,548 firm-fixed price delivery order does not utilize a set-aside program. Pacific Biosciences...
- This federal contract award to Pacific Biosciences of California, Inc. is a delivery order under an Indefinite Delivery Indefinite Quantity (IDIQ) contract #75F40121D00007 with the Food and Drug Administration (FDA). The purpose is to purchase specific supplies and reagents for the PacBio Sequel IIe long-read DNA/RNA sequencer. The award is for a firm fixed-price of $46,341.66, with a period of performance through May 30, 2025. Pacific Biosciences is the original equipment manufacturer for the...
- This is a firm fixed-price purchase order issued by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc., a small business manufacturer of specialized scientific equipment, reagents, and services. The $175,000.00 contract provides a service and maintenance agreement for Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing systems, including software updates and annual preventative maintenance visits. Pacific Biosciences has...